Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progression

References

• Bergsland E, Dickler MN. (2004). Maximizing the potential of bevacizumab in cancer treatment. Oncologist 9:36–42
   PubMed Web of Science ®Google Scholar
• Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–54
   PubMed Web of Science ®Google Scholar
• Broughman JR, Sun L, Umar S, et al. (2006). Chronic PKC-beta activation in HT-29 Cl.19a colonocytes prevents cAMP-mediated ion secretion by inhibiting apical membrane current generation. Am J Physiol Gastrointest Liver Physiol 291:G318–30
   PubMed Web of Science ®Google Scholar
• Cai J, Jiang WG, Ahmed A, Boulton M. (2006). Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. Microvasc Res 71:20–31
   PubMed Web of Science ®Google Scholar
• Casscells W, Naghavi M, Willerson JT. (2003). Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107:2072–5
   PubMed Web of Science ®Google Scholar
• Celletti FL, Waugh JM, Amabile PG, et al. (2001). Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7:425–9
   PubMed Web of Science ®Google Scholar
• Folkman J. (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–6
   PubMed Web of Science ®Google Scholar
• Go AS, Mozaffarian D, Roger VL, et al. (2014). Heart disease and stroke statistics – 2014 update: a report from the american heart association. Circulation 129:e28–292
   PubMed Web of Science ®Google Scholar
• Grunstein J, Masbad JJ, Hickey R, et al. (2000). Isoforms of vascular endothelial growth factor act in a coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 20:7282–91
   PubMed Web of Science ®Google Scholar
• Herbst SM, Klegerman ME, Kim H, et al. (2010). Delivery of stem cells to porcine arterial wall with echogenic liposomes conjugated to antibodies against CD34 and intercellular adhesion molecule-1. Mol Pharm 7:3–11
   PubMed Web of Science ®Google Scholar
• Herrmann J, Lerman LO, Rodriguez-Porcel M, et al. (2001). Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc Res 51:762–6
   PubMed Web of Science ®Google Scholar
• Hitchcock KE, Caudell DN, Sutton JT, et al. (2010). Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model. J Control Release 144:288–95
   PubMed Web of Science ®Google Scholar
• Huang SL, Hamilton AJ, Pozharski E, et al. (2002). Physical correlates of the ultrasonic reflectivity of lipid dispersions suitable as diagnostic contrast agents. Ultrasound Med Biol 28:339–48
   PubMed Web of Science ®Google Scholar
• Hurwitz H, Fehrenbacher L, Novotny W, et al. (2004). Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–42
   PubMed Web of Science ®Google Scholar
• Klegerman ME, Huang S, Parikh D, et al. (2007). Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes. Biochim Biophys Acta 1768:1703–16
   PubMed Web of Science ®Google Scholar
• Klegerman ME, Zou Y, Golunski E, et al. (2014). Use of thermodynamic coupling between antibody-antigen binding and phospholipid acyl chain phase transition energetics to predict immunoliposome targeting affinity. J Liposome Res 24:216–22
   PubMed Web of Science ®Google Scholar
• Kolodgie FD, Virmani R, Burke AP, et al. (2004). Pathologic assessment of the vulnerable human coronary plaque. Heart 90:1385–91
   PubMed Web of Science ®Google Scholar
• Kopechek JA, Haworth KJ, Raymond JL, et al. (2011). Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter. J Acoust Soc Am 130:3472–81
   PubMed Web of Science ®Google Scholar
• Kozloff M, Yood MU, Berlin J, et al. (2009). Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist 14:862–70
   PubMed Web of Science ®Google Scholar
• Kumamoto M, Nakashima Y, Sueishi K. (1995). Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 26:450–6
   PubMed Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–5
   PubMed Web of Science ®Google Scholar
• Laing ST, Kim H, Kopechek JA, et al. (2010). Ultrasound-mediated delivery of echogenic immunoliposomes to porcine vascular smooth muscle cells in vivo. J Liposome Res 20:160–7
   PubMed Web of Science ®Google Scholar
• Laing ST, Moody MR, Kim H, et al. (2012). Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model. Thromb Res 130:629–35
   PubMed Web of Science ®Google Scholar
• Laing ST, Moody M, Smulevitz B, et al. (2011). Ultrasound-enhanced thrombolytic effect of tissue plasminogen activator-loaded echogenic liposomes in an in vivo rabbit aorta thrombus model–brief report. Arterioscler Thromb Vasc Biol 31:1357–9
   PubMed Web of Science ®Google Scholar
• Liang WC, Wu X, Peale FV, et al. (2006). Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 281:951–61
   PubMed Web of Science ®Google Scholar
• Moulton KS, Vakili K, Zurakowski D, et al. (2003). Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci USA 100:4736–41
   PubMed Web of Science ®Google Scholar
• Naghavi M, Libby P, Falk E, et al. (2003). From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II. Circulation 108:1772–8
   PubMed Web of Science ®Google Scholar
• Scott C. (2010). Never again. Nat Biotechnol 28:131
   PubMed Web of Science ®Google Scholar
• Smith DA, Vaidya SS, Kopechek JA, et al. (2010). Ultrasound-triggered release of recombinant tissue-type plasminogen activator from echogenic liposomes. Ultrasound Med Biol 36:145–57
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Toutouzas K, Stefanadi E, et al. (2006). First experimental application of bevacizumab-eluting PC coated stent for inhibition of vasa vasorum of atherosclerotic plaque: angiographic results in a rabbit atheromatic model. Hellenic J Cardiol 47:7–10
   PubMedGoogle Scholar
• Stefanadis C, Toutouzas K, Stefanadi E, et al. (2007). Inhibition of plaque neovascularization and intimal hyperplasia by specific targeting vascular endothelial growth factor with bevacizumab-eluting stent: an experimental study. Atherosclerosis 195:269–76
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Toutouzas K, Stefanadi E, et al. (2008). Avastin-eluting stent: long-term angiographic and clinical follow up. Hellenic J Cardiol 49:188–90
   PubMed Web of Science ®Google Scholar
• Tiukinhoy SD, Khan AA, Huang S, et al. (2004). Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol 39:104–10
   PubMed Web of Science ®Google Scholar
• Tiukinhoy SD, Mahowald ME, Shively VP, et al. (2000). Development of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Invest Radiol 35:732–8
   PubMed Web of Science ®Google Scholar
• Toutouzas K, Karabelas J, Vaina S, Stefanadis C. (2007). Antivascular endothelial growth factor-a treatment: new perspectives for high-risk plaque stabilization. J Am Coll Cardiol 50:186
   PubMed Web of Science ®Google Scholar
• Varey AH, Rennel ES, Qiu Y, et al. (2008). VEGF 165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer 98:1366–79
   PubMed Web of Science ®Google Scholar
• Wilson SH, Herrmann J, Lerman LO, et al. (2002). Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 105:415–18
   PubMed Web of Science ®Google Scholar
• Xu H, Czerwinski P, Hortmann M, et al. (2008). Protein kinase C alpha promotes angiogenic activity of human endothelial cells via induction of vascular endothelial growth factor. Cardiovasc Res 78:349–55
   PubMed Web of Science ®Google Scholar
• Zuidam NJ, Vrueh RD, Crommelin DJA. (2003). Characterization of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes. 2 edn. New York: Oxford University Press, 31--78
   Google Scholar